David Hung, M.D.

David Hung, M.D.

President and Chief Executive OfficeratNuvation Bio· In proxies 2022–2023

Pay in FY2023-46% from the year before

David Hung, M.D. was paid $4.3M in FY2023 (Dec), down 46%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Nuvation Bio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Nuvation BioPublic company · 4 yr
    • President and Chief Executive Officer2022 – Present · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?